{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:06:46Z","timestamp":1784027206925,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004543","name":"Chinese Scholarship Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15570-w","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:46:22Z","timestamp":1773042382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prediction of treatment outcome in nasopharyngeal carcinoma patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Guanzhi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna M.","family":"Sijtsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen","family":"van der Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne V.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingrui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"11","key":"15570_CR1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.oraloncology.2015.08.005","volume":"51","author":"B Zhang","year":"2015","unstructured":"Zhang B, Mo Z, Du W, Wang Y, Liu L, Wei Y. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. Oral Oncol. 2015;51(11):1041\u20136.","journal-title":"Oral Oncol"},{"issue":"6","key":"15570_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1470-2045(23)00163-8","volume":"24","author":"C Petit","year":"2023","unstructured":"Petit C, Lee A, Ma J, Lacas B, Ng WT, Chan ATC, et al. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis. Lancet Oncol. 2023;24(6):611\u201323.","journal-title":"Lancet Oncol"},{"issue":"12","key":"15570_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jamaoncol.2024.4354","volume":"10","author":"JJ Pan","year":"2024","unstructured":"Pan JJ, Mai HQ, Ng WT, Hu CS, Li JG, Chen XZ, et al. Ninth version of the AJCC and UICC nasopharyngeal cancer TNM staging classification. JAMA Oncol. 2024;10(12):1627\u201335.","journal-title":"JAMA Oncol"},{"issue":"4","key":"15570_CR4","doi-asserted-by":"publisher","first-page":"104513","DOI":"10.1016\/j.esmoop.2025.104513","volume":"10","author":"P Blanchard","year":"2025","unstructured":"Blanchard P, De Felice F, Chua MLK. Advances in individualization of systemic treatment for locoregionally advanced nasopharyngeal carcinoma: a systematic review. ESMO Open. 2025;10(4):104513.","journal-title":"ESMO Open"},{"issue":"3","key":"15570_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","volume":"80","author":"SZ Lai","year":"2011","unstructured":"Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011;80(3):661\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"15570_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","volume":"110","author":"AW Lee","year":"2014","unstructured":"Lee AW, Ng WT, Chan LL, Hung WM, Chan CC, Sze HC, et al. Evolution of treatment for nasopharyngeal cancer\u2013success and setback in the intensity-modulated radiotherapy era. Radiother Oncol. 2014;110(3):377\u201384.","journal-title":"Radiother Oncol"},{"issue":"3","key":"15570_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.radonc.2013.08.003","volume":"110","author":"C Chen","year":"2014","unstructured":"Chen C, Shen LJ, Li BF, Gao J, Xia YF. Smoking is a poor prognostic factor for male nasopharyngeal carcinoma treated with radiotherapy. Radiother Oncol. 2014;110(3):409\u201315.","journal-title":"Radiother Oncol"},{"issue":"3","key":"15570_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.radonc.2012.09.001","volume":"104","author":"R Guo","year":"2012","unstructured":"Guo R, Sun Y, Yu XL, Yin WJ, Li WF, Chen YY, et al. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? Radiother Oncol. 2012;104(3):294\u20139.","journal-title":"Radiother Oncol"},{"issue":"7","key":"15570_CR9","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ijc.31856","volume":"144","author":"VH Lee","year":"2019","unstructured":"Lee VH, Kwong DL, Leung TW, Choi CW, O\u2019Sullivan B, Lam KO, et al. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification. Int J Cancer. 2019;144(7):1713\u201322.","journal-title":"Int J Cancer"},{"issue":"5","key":"15570_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/hed.23642","volume":"37","author":"XL Luo","year":"2015","unstructured":"Luo XL, He W, Huang H, Chen QY, Liang Y, Mai HQ, et al. Design of a prognostic score model for nasopharyngeal carcinoma. Head Neck. 2015;37(5):624\u20139.","journal-title":"Head Neck"},{"issue":"6","key":"15570_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.21037\/tcr-22-1196","volume":"11","author":"Z Dai","year":"2022","unstructured":"Dai Z, Zhong Y. Bioinformatics analysis based on ferroptosis-related lncrnas: construction of a clinical prognostic model for nasopharyngeal carcinoma and correlation analysis. Transl Cancer Res. 2022;11(6):1665\u201377.","journal-title":"Transl Cancer Res"},{"key":"15570_CR12","doi-asserted-by":"crossref","unstructured":"Yang DX, Khera R, Chang E, Joel M, Janda G, Park HSM, et al. Comparison of machine learning approaches for missing data imputation among Non-Small cell lung cancer patients. Int J Radiation Oncology*Biology*Physics. 2021;111(3):S115.","DOI":"10.1016\/j.ijrobp.2021.07.264"},{"key":"15570_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987."},{"issue":"28","key":"15570_CR14","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1002\/sim.7179","volume":"36","author":"Y Vergouwe","year":"2017","unstructured":"Vergouwe Y, Nieboer D, Oostenbrink R, Debray TPA, Murray GD, Kattan MW, et al. A closed testing procedure to select an appropriate method for updating prediction models. Stat Med. 2017;36(28):4529\u201339.","journal-title":"Stat Med"},{"key":"15570_CR15","first-page":"100464","volume":"24","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li YH, Cui ZY, Li L, Nie XQ, Yu CD, et al. Prevalence of tobacco dependence and associated factors in china: findings from nationwide China health literacy survey during 2018-19. Lancet Reg Health West Pac. 2022;24:100464.","journal-title":"Lancet Reg Health West Pac"},{"issue":"24","key":"15570_CR16","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1056\/NEJMoa032260","volume":"350","author":"JCWW Lin","year":"2004","unstructured":"Lin JCWW, Chen KY, Wei YH, Liang WM, Jan JS, Jiang RS. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2004;350(24):2461\u201370.","journal-title":"N Engl J Med"},{"issue":"1","key":"15570_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijrobp.2005.12.003","volume":"65","author":"JL Yi","year":"2006","unstructured":"Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 2006;65(1):161\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"15570_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ijrobp.2004.11.002","volume":"62","author":"SA Yeh","year":"2005","unstructured":"Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys. 2005;62(3):672\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"15570_CR19","doi-asserted-by":"crossref","unstructured":"Tang LQ, Li CF, Li J, Chen WH, Chen QY, Yuan LX, et al. Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst. 2016;108(1):djv291.","DOI":"10.1093\/jnci\/djv291"},{"key":"15570_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejca.2022.10.011","volume":"178","author":"LV van Dijk","year":"2023","unstructured":"van Dijk LV, Mohamed AS, Ahmed S, Nipu N, Marai GE, Wahid K, et al. Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer. Eur J Cancer. 2023;178:150\u201361.","journal-title":"Eur J Cancer"},{"key":"15570_CR21","doi-asserted-by":"crossref","unstructured":"Guo RTL, Mao YP, Du XJ, Chen L, Zhang ZC, et al. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma. Cancer. 2019;125(1):79\u201389.","DOI":"10.1002\/cncr.31741"},{"issue":"7","key":"15570_CR22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ijc.31856","volume":"144","author":"VHKD Lee","year":"2019","unstructured":"Lee VHKD, Leung TW, Choi CW, O\u2019Sullivan B, Lam KO, Lai V, et al. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification. Int J Cancer. 2019;144(7):1713\u201322.","journal-title":"Int J Cancer"},{"issue":"21","key":"15570_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","volume":"94","author":"TC Anthony","year":"2002","unstructured":"Anthony TC, Chan YMDL, Benny Zee, Lisa YS, Chan BBY, Ma S-F, Leung, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst. 2002;94(21):1614\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"246","key":"15570_CR24","first-page":"1","volume":"9","author":"S-s Guo","year":"2014","unstructured":"Guo S-s, Huang P-y, Chen Q-y, Liu H, Tang L-q, Zhang L, et al. The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy. Radiat Oncol. 2014;9(246):1\u20139.","journal-title":"Radiat Oncol"},{"key":"15570_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jclinepi.2019.02.016","volume":"110","author":"P Madley-Dowd","year":"2019","unstructured":"Madley-Dowd P, Hughes R, Tilling K, Heron J. The proportion of missing data should not be used to guide decisions on multiple imputation. J Clin Epidemiol. 2019;110:63\u201373.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15570-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15570-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15570-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:29:33Z","timestamp":1778189373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15570-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15570"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15570-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the principles of the Declaration of Helsinki (2013 revision) and approved by the Institutional Review Board of Hunan Cancer Hospital and the Institutional Review Board of Cancer Hospital of Shantou University Medical College. The requirement for written individual informed consent was waived by both committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. Langendijk was member of the Global Advisory Board of IBA (honorarium paid to the UMCG Research BV and the RayCare International Advisory Board of RaySearch). The department of Radiation Oncology of UMCG has research agreements with IBA, RaySearch, Siemens, Elekta, Mirada and Leoni. All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}